Edgewise Therapeutics Inc (EWTX)
$38.90 -0.03% Close Oct 30, 2026 Live
Edgewise Therapeutics stock today
Edgewise Therapeutics closed at $38.90 on October 30, 2026, down 0.03% on the day. Over the past year it returned +108.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $4.18 billion.
$20.00$30.00$40.00$50.00
NovJan 2026MarMayJulSep
| Period | EWTX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.2% | -0.9% |
| 3 months | -5.4% | +2.1% |
| Year to date | +56.8% | +11.7% |
| 1 year | +108.4% | +12.4% |
| 3 years | +469.5% | +88.5% |
| 5 years | +135.8% | +76.0% |
Key statistics
- Market value
- $4.18B
- 52-week range
- $17.09 to $48.35
- Next report
- Nov 5, 2026 (estimated)
About Edgewise Therapeutics
Edgewise Therapeutics develops pharmaceutical treatments for rare genetic disorders and cardiovascular diseases.
Sector: Health Care
More on Edgewise Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $2,358 today
No forecast, no recommendation. This page describes Edgewise Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.